@article{APM8926,
author = {Aaron Woo and Terence Fu and Marko Popovic and Edward Chow and David Cella and C. Shun Wong and Henry Lam and Natalie Pulenzas and Breanne Lechner and Sherlyn Vuong and Vithusha Ganesh and Andrew Bottomley},
title = {Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer},
journal = {Annals of Palliative Medicine},
volume = {5},
number = {1},
year = {2016},
keywords = {},
abstract = {This review compares the development, characteristics, validity, and reliability of two well-known quality of life (QOL) assessment tools used in patients with gastric cancer: the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Stomach (EORTC QLQ-STO22) and the Functional Assessment of Cancer Therapy-Gastric (FACT-Ga). A literature search was conducted using MEDLINE, EMBASE, and Cochrane CENTRAL (inception to April 2015) to identify studies that discussed the development, characteristics, validity and reliability of the EORTC QLQ-STO22 or the FACT-Ga. The QLQ-STO22 was developed with collaboration with patients, healthcare professionals and literature review and was mainly field tested in European countries. Conversely, items on the FACT-Ga were generated from interviews with patients and healthcare professionals concurrently in North America and Asia. While both modules involve a 7-day recall period and use Likert scales, the QLQ-STO22 and FACT-Ga differ in terms of QOL domain focus, quantity and presentation of items, response options, and scoring. However, both tools show good internal consistency, test-retest reliability, sensitivity to change and construct validity. In addition, both questionnaires have been internationally validated within a large sample of patients undergoing a variety of treatments, thus demonstrating their cross-cultural applicability. The EORTC QLQ-STO22 and FACT-Ga are both valid and reliable tools with unique strengths and weaknesses. Selection between instruments should consider specific patient characteristics and goals of the study.},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/8926}
}